Copyright
©The Author(s) 2019.
World J Gastroenterol. May 21, 2019; 25(19): 2338-2353
Published online May 21, 2019. doi: 10.3748/wjg.v25.i19.2338
Published online May 21, 2019. doi: 10.3748/wjg.v25.i19.2338
Figure 3 Kaplan-Meier curves for survival of the gastric cancer patients with clinically positive para-aortic node metastasis.
A: Overall survival and progression-free survival of all patients; B: Overall survival of patients who underwent chemotherapy with or without D2 resection; C: Progression-free survival of patients who underwent chemotherapy with or without D2 resection; D: Overall survival of all patients assessed by overall response; E: Overall survival of all patients assessed by chemotherapy response of the primary tumor; F: Overall survival of all patients assessed by chemotherapy response of the metastatic para-aortic lymph node. CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease; NE: Not evaluable.
- Citation: Zheng XH, Zhang W, Yang L, Du CX, Li N, Xing GS, Tian YT, Xie YB. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis. World J Gastroenterol 2019; 25(19): 2338-2353
- URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2338.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i19.2338